000 01391 a2200397 4500
005 20250514061040.0
264 0 _c20030416
008 200304s 0 0 eng d
022 _a1527-9995
024 7 _a10.1016/s0090-4295(02)02268-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFreedland, Stephen J
245 0 0 _aDefining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.
_h[electronic resource]
260 _bUrology
_cFeb 2003
300 _a365-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAged
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLymph Node Excision
_xmethods
650 0 4 _aLymph Nodes
_xpathology
650 0 4 _aLymphatic Metastasis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xblood
650 0 4 _aProstate
_xpathology
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatectomy
_xmethods
650 0 4 _aProstatic Neoplasms
_xblood
650 0 4 _aSurvival Analysis
700 1 _aSutter, Mark E
700 1 _aDorey, Frederick
700 1 _aAronson, William J
773 0 _tUrology
_gvol. 61
_gno. 2
_gp. 365-9
856 4 0 _uhttps://doi.org/10.1016/s0090-4295(02)02268-9
_zAvailable from publisher's website
999 _c12394770
_d12394770